Board Change • May 20
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 2 highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Director Allan Larsen was the last director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • May 01
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 2 highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Director Allan Larsen was the last director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Announcement • Apr 17
Eden Innovations Ltd has filed a Follow-on Equity Offering in the amount of AUD 4.05 million. Eden Innovations Ltd has filed a Follow-on Equity Offering in the amount of AUD 4.05 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 22,500,000
Price\Range: AUD 0.18
Discount Per Security: AUD 0.0108
Transaction Features: Subsequent Direct Listing Board Change • Dec 24
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Allan Larsen was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Dec 19
Eden Innovations Ltd has completed a Follow-on Equity Offering in the amount of AUD 4.348 million. Eden Innovations Ltd has completed a Follow-on Equity Offering in the amount of AUD 4.348 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 117,085,716
Price\Range: AUD 0.035
Discount Per Security: AUD 0.0021
Security Features: Attached Options
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 7,142,857
Price\Range: AUD 0.035
Discount Per Security: AUD 0.0021
Security Features: Attached Options
Transaction Features: Subsequent Direct Listing Announcement • Nov 10
Eden Innovations Ltd has filed a Follow-on Equity Offering in the amount of AUD 4.348414 million. Eden Innovations Ltd has filed a Follow-on Equity Offering in the amount of AUD 4.348414 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 117,097,538
Price\Range: AUD 0.035
Discount Per Security: AUD 0.0021
Security Features: Attached Options
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 7,142,857
Price\Range: AUD 0.035
Discount Per Security: AUD 0.0021
Security Features: Attached Options
Transaction Features: Subsequent Direct Listing Announcement • Oct 28
Eden Innovations Ltd, Annual General Meeting, Nov 28, 2025 Eden Innovations Ltd, Annual General Meeting, Nov 28, 2025. Location: level 15, 197 st georges terrace, western australia, perth Australia Announcement • Jun 21
Eden Innovations Ltd has filed a Follow-on Equity Offering in the amount of AUD 6.579881 million. Eden Innovations Ltd has filed a Follow-on Equity Offering in the amount of AUD 6.579881 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 99,497,025
Price\Range: AUD 0.04
Security Features: Attached Options
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 65,000,000
Price\Range: AUD 0.04
Transaction Features: Rights Offering Announcement • Feb 28
Eden Innovations Ltd to Report Q2, 2025 Results on Feb 28, 2025 Eden Innovations Ltd announced that they will report Q2, 2025 results on Feb 28, 2025 Board Change • Feb 04
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Allan Larsen was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Nov 01
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Executive Director Allan Larsen was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Oct 31
Eden Innovations Ltd, Annual General Meeting, Nov 29, 2024 Eden Innovations Ltd, Annual General Meeting, Nov 29, 2024. Location: at level 15, 197 st georges terrace, perth Australia Reported Earnings • Aug 31
Full year 2024 earnings released: AU$0.002 loss per share (vs AU$0.006 loss in FY 2023) Full year 2024 results: AU$0.002 loss per share (improved from AU$0.006 loss in FY 2023). Revenue: AU$2.19m (down 54% from FY 2023). Net loss: AU$7.37m (loss narrowed 59% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has fallen by 56% per year, which means it is performing significantly worse than earnings. New Risk • Mar 02
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$5.4m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$5.4m free cash flow). Share price has been highly volatile over the past 3 months (39% average weekly change). Earnings have declined by 10% per year over the past 5 years. Market cap is less than US$10m (AU$9.20m market cap, or US$6.00m). Minor Risks Shareholders have been diluted in the past year (25% increase in shares outstanding). Revenue is less than US$5m (AU$2.5m revenue, or US$1.7m). Announcement • Dec 01
Eden Innovations Ltd announced a financing transaction Eden Innovations Ltd announced a private placement that it will issue 10,043,268 common shares on November 30, 2023. The transaction has been approved by the board of the directors of the company. Announcement • Oct 27
Eden Innovations Ltd, Annual General Meeting, Nov 30, 2023 Eden Innovations Ltd, Annual General Meeting, Nov 30, 2023, at 11:00 W. Australia Standard Time. Location: Level 15, 197 St Georges Terrace, Perth Australia Agenda: To consider and approve the Annual Financial Report for the financial year ended 30 June 2023 and the Director's Report and Auditor's Report for that financial year; to consider adoption of remuneration report; to consider election of director; to consider Ratification and Approval of Issue of Shares and Options; to consider Ratification and Approval of Issue of Broker Options; to consider Ratification of Agreement to Issue Shares to the Company's CFO and Company Secretary; to consider Approval of Issue of Shares and Options to Noble in partial satisfaction of debt; and to consider other business matter. Announcement • Sep 02
Eden Innovations Ltd has completed a Follow-on Equity Offering in the amount of AUD 1.1 million. Eden Innovations Ltd has completed a Follow-on Equity Offering in the amount of AUD 1.1 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 366,666,665
Price\Range: AUD 0.003
Discount Per Security: AUD 0.00018
Transaction Features: Subsequent Direct Listing Reported Earnings • Sep 01
Full year 2023 earnings released: AU$0.006 loss per share (vs AU$0.003 loss in FY 2022) Full year 2023 results: AU$0.006 loss per share (further deteriorated from AU$0.003 loss in FY 2022). Revenue: AU$4.75m (up 14% from FY 2022). Net loss: AU$17.9m (loss widened 169% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has fallen by 45% per year, which means it is performing significantly worse than earnings. New Risk • Aug 31
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$7.7m free cash flow). Share price has been highly volatile over the past 3 months (31% average weekly change). Market cap is less than US$10m (AU$12.0m market cap, or US$7.77m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (16% increase in shares outstanding). Revenue is less than US$5m (AU$5.2m revenue, or US$3.4m). Reported Earnings • Mar 03
First half 2023 earnings released: EPS: AU$0 (vs AU$0.001 loss in 1H 2022) First half 2023 results: EPS: AU$0. Revenue: AU$3.09m (up 53% from 1H 2022). Net loss: AU$13.0m (loss widened 407% from 1H 2022). Announcement • Feb 07
Eden Innovations Ltd Announces Board Changes Eden Innovations Ltd. announced that Dr. Stephen Dunmead who has been a non-executive director of Eden for almost five years has resigned and Dr. Allan Godsk Larsen, who has been with Eden since 2016, has been appointed as an executive director to replace Dr. Dunmead on the Board. Dr. Larsen is highly qualified with a Ph.D. in electro-chemistry from Aarhus in Denmark in 2008. After completing his doctorate and a year consulting to the Danish Technological Institute, he undertook a three-year Postdoctoral Fellowship at Sydney University. Since then Allan has held the following positions: Two and a half years as Senior Scientist R&D at Cap-XX Ltd. in Sydney, developing super capacitors including working with carbon nanotubes; Almost five and a half years as Catalyst Specialist and Sales Manager at Haldor Topsøe, after which: Allan joined Eden in November 2016 where he has held the following positions: November 2016 to April 2018- Product Development Manager (including having designed and developed the EdenCrete® Pz range of products); and April 2018 to present- Chief Scientist and Manager of International Business. Announcement • Feb 02
Eden Innovations Ltd Announces Resignation of Lazaros Nikeas as Non-Executive Director Eden Innovations Ltd. advises that Mr. Lazaros ("Laz") Nikeas, who is based in the USA, has resigned as Non-Executive Director of the Company. Laz has been a valued member of the Board since his appointment in May 2018. The Board and Company thank Laz for his contribution over the past 4.5 years and extend their best wishes to Laz for the future. Announcement • Jan 14
Eden Innovations Ltd Receives the Results from the Two and Half Year-Long Field Trial on the Little River Bridge in Georgia Eden Innovations Ltd. report that it has received the results from the two and a half year-long field trial on the Little River Bridge in Georgia that was undertaken with Georgia Department of Transportation (GDOT) in November 2019 to assess the performance benefits delivered by EdenCrete® to the concrete used in the new bridge decking. After two and a half years of service, cores from the EdenCrete® and the reference concrete were taken from the decking, pulverised and the depth of chloride penetration in each was then measured. Compared to the reference, the EdenCrete® delivered: 37.5% reduction in chloride concentration at 14.5 mm depth; 50% reduction in chloride concentration at 18 mm depth. Relevantly, a meeting with GDOT is presently being arranged to review these results, and Eden is optimistic that this may lead to GDOT deciding to use EdenCrete® inappropriate bridge projects. Board Change • Jan 12
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. No independent directors (4 non-independent directors). Non-Executive Director Lazaros Nikeas was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. 
